Publication | Closed Access
The Cost of Treatment of Skeletal-Related Events in Patients with Bone Metastases from Lung Cancer
157
Citations
23
References
2004
Year
The economic burden of SREs in patients with bone metastases of lung cancer is substantial. Intravenous bisphosphonates, such as zoledronic acid, which have been shown to prevent these events, may reduce these costs.
| Year | Citations | |
|---|---|---|
Page 1
Page 1